Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63,223,223
-
Total 13F shares
-
38,053,058
-
Share change
-
+2,436,706
-
Total reported value
-
$973,207,097
-
Put/Call ratio
-
0%
-
Price per share
-
$25.58
-
Number of holders
-
134
-
Value change
-
+$63,021,790
-
Number of buys
-
89
-
Number of sells
-
45
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q2 2023
As of 30 Jun 2023,
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by
134 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,053,058 shares.
The largest 10 holders included
VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., BlackRock Inc., PERCEPTIVE ADVISORS LLC, NEXT CENTURY GROWTH INVESTORS LLC, Driehaus Capital Management LLC, Point72 Asset Management, L.P., CIBC Private Wealth Group, LLC, EMERALD ADVISERS, LLC, and LOOMIS SAYLES & CO L P.
This page lists
135
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.